USC.edu
Are You a Patient?

John M. Ringman, MD, MS

Professor of Clinical Neurology

Helene and Lou Galen Endowed Professorship in Neurology

Image of John M. Ringman, MD, MS
Is this your profile? Click to edit
Email [email protected]
CTSI Profile

Research Funding

  • Validation of Imaging and Blood-based Small Vessel VCID Biomarkers in Multiethnic Population
    NIH · U01NS100614 · Sep 30, 2021 – Jul 31, 2026 · Role: Co-Principal Investigator
  • Phenotype and Genotype of Autosomal Dominant Alzheimer's Disease in Jalisco, Mexico
    NIH · R01AG069013 · Sep 15, 2020 – May 31, 2025 · Role: Principal Investigator
  • Motor, Visual, and Olfactory Changes in Genetic Subtypes of Alzheimer?s Disease
    NIH · R01AG062007 · Feb 15, 2019 – Nov 30, 2024 · Role: Principal Investigator
  • Validation of Imaging and Blood-based Small Vessel VCID Biomarkers in Multiethnic Population
    NIH · UF1NS100614 · Sep 30, 2016 – Jul 31, 2023 · Role: Co-Principal Investigator
  • Imaging Cerebral and Retinal Microvasculature in Cerebral Small Vessel Disease
    NIH · UH3NS100614 · Sep 30, 2016 – Jul 31, 2021 · Role: Co-Principal Investigator
  • Imaging Cerebral and Retinal Microvasculature in Cerebral Small Vessel Disease
    NIH · UH2NS100614 · Sep 30, 2016 – Jul 31, 2018 · Role: Co-Principal Investigator
  • The structural and functional connectome across Alzheimer's disease subtypes
    NIH · U01AG051218 · Sep 30, 2015 – Jun 30, 2021 · Role: Principal Investigator
  • Establishing Infrastructure for Prevention of familial AD in Mexico
    NIH · R21TW009787 · Sep 1, 2013 – Apr 30, 2018 · Role: Principal Investigator
  • FMRI in Pre-Symptomatic PS1-related Alzheimer's Disease
    NIH · K08AG022228 · Aug 1, 2003 – Jul 31, 2007 · Role: Principal Investigator
  • UCLA Alzheimer's Disease Research Center
    NIH · P50AG016570 · Apr 5, 1999 – Mar 31, 2016 · Role: Co-Principal Investigator

Publications

  • Presenilin-1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage. Alzheimers Dement. 2024 04; 20(4):2680-2697.. View in PubMed
  • Systematic proteomics in Autosomal dominant Alzheimer’s disease reveals decades-early changes of CSF proteins in neuronal death, and immune pathways. medRxiv. 2024 Jan 13.. View in PubMed
  • Vessel density mapping of small cerebral vessels on 3D high resolution black blood MRI. Neuroimage. 2024 02 01; 286:120504.. View in PubMed
  • Effect of Genetic Risk on the Relationship Between rs-fMRI Complexity and Tau and Amyloid PET in Alzheimer’s Disease. J Alzheimers Dis. 2024; 101(2):429-435.. View in PubMed
  • Use of the Spanish English Neuropsychological Assessment Scale in older adult Latines and those at risk for autosomal dominant Alzheimer’s disease. J Clin Exp Neuropsychol. 2023 08; 45(6):553-569.. View in PubMed
  • Age of onset predicted by Aβ profiling in a novel PSEN1 (I180F) mutation. Neurosci Lett. 2024 01 18; 820:137591.. View in PubMed
  • Association Between Self- and Proxy-Reported Depression and Quality of Life in Mild-Moderate Alzheimer’s Disease. Am J Geriatr Psychiatry. 2024 01; 32(1):58-67.. View in PubMed
  • Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies LRRC4C, LHX5-AS1 and nominates ancestry-specific loci PTPRK , GRB14 , and KIAA0825 as novel risk loci for Alzheimer’s disease: the Alzheimer’s Disease Genetics Consortium. medRxiv. 2023 Jul 08.. View in PubMed
  • Retinotopic degeneration of the retina and optic tracts in autosomal dominant Alzheimer’s disease. Alzheimers Dement. 2023 11; 19(11):5103-5113.. View in PubMed
  • Vessel Density Mapping of Cerebral Small Vessels on 3D High Resolution Black Blood MRI. bioRxiv. 2023 Mar 21.. View in PubMed

Similar People